Efficacy of Gamaline V Medication to Improve Breast Pain in Women: a Comparative Research Between Groups

Efficacy of Gamaline V in Reducing the Intensity of Mastalgia in Female Patients: a Randomized Clinical Trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

REBEC

Registry ID

RBR-388nknt

Enrollment

Unknown

Registered

2024-08-22

Start date

2024-05-01

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mastodynia

Interventions

This is a two-arm, double-blind, randomized controlled clinical study. Experimental group: 40 women with mastalgia will use Gamaline v 1 tablet orally a day for 30 days. Control group: 40 women with m

N04.590.607.500

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Women; over 18 years of age; complaining of breast pain

Exclusion criteria

Exclusion criteria: Breast cancer patients; people with schizophrenia

Design outcomes

Primary

Measure	Time frame
Compare the improvement in mastalgia between groups	—

Secondary

Measure	Time frame
No secondary outcomes are expected	—

Countries

Brazil

Contacts

Public ContactRafael da Sa

Universidade do Oeste Paulista

rafasamed@hotmail.com+55 (018) 981514255

Outcome results

None listed

Source: REBEC (via WHO ICTRP)